CXCL12 and melanoma: For instance, K5-NS,OS was shown to inhibit the SDF-1/CXCL12 chemokine-mediated B16 melanoma cell proliferation and adhesion to endothelial cells and activated platelets, likely by interfering with the CXCL12–CXCR4 interaction [234].